product

Description

Home Non-invasive ventilation (NIV) with bi-level positive airway pressure (BiPAP) is commonly used to treat patients admitted to hospital with acute hypercapnic respiratory failure (AHRF) secondary to an acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Home non-invasive ventilation (NIV) adherence for chronic respiratory failure treatment of obesity hypoventilation syndrome (OHS) vs. chronic obstructive lung disease (COPD). OHS and COPD are both common respiratory conditions that can lead to chronic hypercapnic respiratory failure with the need for domiciliary NIV. Variability of NIV practice is a known issue.

Application

Chronic Obstructive Pulmonary Disease, it is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.

Suppress the inflammation in small airways, it is pivotal as the pathological features of bronchial asthma. Progression of airflow limitation is associated with the increase in accumulation of mucus exudates in the lumen and infiltration and a variety of inflammatory cells are present in the airways of patients with COPD.

Advantage

Professional brand trusted by more than 3000 hospitals.

Built in ozone module, automatic cleaning, prevent infection.

Intelligent preheating, avoid dry and cold.

CPAP mode, the patient has strong spontaneous breathing, and the ventilator provides the same pressure in both inspiratory and expiratory phases to help the patient open the airway.

S mode, the ventilator is triggered by the patient. IPAP and EPAP are provided, and patients control respiratory rate and I/E ratio and inspiratory time autonomously.

S/T mode, when the respiratory rate is less than the backup BPM, the S mode works. When the respiratory rate is more than the backup BPM, the T mode works.

Specifications